Celldex Therapeutics, Inc. announced it raised $62.5 Million in an initial filing from an offering of $62.5 Million

Company

Location

About

Celldex is pioneering new horizons in immunology to deliver life-changing therapies. We are relentless in our pursuit of novel antibody-based treatments that engage the human immune system and directly affect critical pathways to improve the lives of patients with allergic, inflammatory and autoimmune disorders.